Graves Light Lenhart Wealth, Inc. Novartis Ag Transaction History

Graves Light Lenhart Wealth, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$80.52 - $93.75 $4,831 - $5,625	-60 Reduced 9.2%	592 $50,000
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $104,303 - $117,987	-1,302 Reduced 66.63%	652 $57,000
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $8,767 - $9,694	110 Added 5.97%	1,954 $171,000
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $5,561 - $6,469	68 Added 3.83%	1,844 $151,000
Q2 2021 Jul 12, 2021	BUY	$85.24 - $94.15 $11,933 - $13,181	140 Added 8.56%	1,776 $162,000
Q1 2021 Apr 09, 2021	SELL	$83.5 - $98.47 $3,507 - $4,135	-42 Reduced 2.5%	1,636 $140,000
Q4 2020 Feb 04, 2021	BUY	$78.07 - $94.43 $131,001 - $158,453	1,678 New	1,678 $158,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $223B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Graves Light Lenhart Wealth, Inc., based on Form 13F filings with the SEC.

Stay updated on Graves Light Lenhart Wealth, Inc. with notifications on news.